ARTICLE | Editor's Commentary
Makary facing key test: a Perspective
The FDA commissioner must swiftly reverse decision to conduct a political review of a COVID vaccine — or risk irreparable damage to FDA’s credibility
April 5, 2025 12:41 AM UTC
Credibility is earned by the drop and lost by the bucket. FDA Commissioner Marty Makary is on the verge of kicking over the bucket.
In his first days as commissioner, he allowed Principal Deputy Commissioner Sara Brenner to put an 11th-hour hold on the approval of a COVID-19 vaccine from Novavax Inc. (NASDAQ:NVAX). ...
BCIQ Company Profiles